跳至主要内容
临床试验/CTIS2024-515580-64-00
CTIS2024-515580-64-00进行中(未招募)1 期

Phase 1b trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.

Fondazione IRCCS Istituto Nazionale Dei Tumori0 个研究点目标入组 18 人开始时间: 2024年7月5日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
A phase I study of FLOT in metastatic gastric cancerGastric cancer
JPRN-jRCTs041200044Masuishi Toshiki36
已完成
1 期
Phase I Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan(FOLFOXIRI) for Metastatic or Reccurence Colorectal CancerColorectal Cancer
JPRN-UMIN000000883Department of Clinical Oncology, Conprehensive Cancer Center, Saitama Medical University International Medical Center10
已完成
不适用
A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinomaColon, Rectal cancer1. Malignant neoplasm of colon2. Malignant neoplasm of rectumCancer
ISRCTN88796215Wyeth-Lederle Ltd (UK)
已完成
不适用
Feasibility study of 5-fluorouracil, leucovorin and paclitaxel (FLTAX) in peritoneal disseminated gastric cancer with massive ascites or inadequate oral intakeGastric cancer
JPRN-UMIN000002093ational Cancer Center Hospital20
进行中(未招募)
1 期
al-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary-tract cancerocally advanced or metastatic, non resectable, adenocarcinoma of the biliary tract including intrahepatic and extrahepatic bile ductMedDRA version: 21.1Level: LLTClassification code 10025734Term: Malignant neoplasm of biliary tract, part unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10008594Term: Cholangiocarcinoma non-resectableSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10028982Term: Neoplasm biliary tractSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10077846Term: Cholangiocarcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2016-002467-34-DEAIO-Studien-gGmbH92